3D Tissue Models

View Profile

Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors Review type Summary Keywords File filename File mime type
1. 2009 Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications Clin Cancer Res. 2009, in press.
2. 2009 Evolution of clinical trials in head and neck cancer Crit Rev Oncol Hematol. 2009, Vol 71, No 1, p29-42.
3. 2009 Infusion reactions to monoclonal antibodies for solid tumors: Immunologic mechanisms and risk factors ONCOL. 2009, Vol 23, No 2 Suppl 1, p14-17.
4. 2009 A feed-forward loop involving Protein Kinase C Alpha and microRNAs regulates tumor cell cycle Cancer Res. 2009, Vol 69, No 1, p65-74.
5. 2009 Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer J Clin Invest. 2009, Vol 119, No 6, p1571-82.
6. 2009 Human papillomavirus in early laryngeal carcinoma Laryngoscope. 2009, Jun 1 [Epub].
7. 2009 Hypothyroidism as a consequence of Intensity-Modulated Radiation Therapy with concurrent Taxane-based chemotherapy for locally-advanced head-and-neck cancer Int J Radiat Oncol Biol Phys. 2009, Jul 3 [Epub].
8. 2009 Validation of Lysyl Oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma – Radiation Therapy Oncology Group Trial 90-03 J Clin Oncol. 2009, Aug 10 [Epub].
9. 2009 Reliability and validity of the Vanderbilt Head and Neck Symptom Survey: A tool to assess symptom burden in patients treated with chemoradiation Head & Neck. 2009, Jul 22 [Epub].
10. 2009 Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma Ann. Oncol. 2009, in press.
11. 2008 Managing premedications and risk of reactions to infusional monoclonal antibody therapy Oncologist. 2008, Vol 13, No 6, p725-732.
12. 2008 Update in molecular diagnostic tests in head and neck cancer Semin Oncol. 2008, Vol 35, No 3, p198-210.
13. 2008 Gene expression profiles identify epithelial-to-mesenchymal transition and activation of Nuclear Factor-ĸB signaling as characteristics of a high-risk head and neck squamous cell carcinoma Cancer Res. 2006, Vol 66, No 16, p8210-8218.
14. 2008 Microsatellite mutations in buccal cells are associated with aging and head and neck carcinoma Br J Cancer. 2008, Vol 98, No 3, p619-626.
15. 2008 Cetuximab-induced anaphylaxis and IgE antibodies against galactose-alpha-1,3-galactose N Engl J Med. 2008, Vol 358, No 11, p1109-1117.
16. 2008 Phase II trial of irinotecan plus cisplatin in patients with recurrent or metastatic squamous carcinoma of the head and neck Cancer. 2008, Vol 113, No 1, p186-192.
17. 2008 Transforming Growth Factor-beta engages TACE and ErbB3 to activate PI3K/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab Mol Cell Biol. 2008, Vol 28, No 18, p5605-5620.
18. 2008 Cetuximab-induced hypersensitivity: case reports and discussion of management Oncol Nurse. 2008, Vol 1, No 2, p17-19.
19. 2007 Gene expression profiles as markers of aggressive disease – EGFR as a factor Int J Radiat Oncol Biol Phys. 2007, Vol 69, No 2 Suppl, pS102-S105.
20. 2007 Strategic plans to promote head and neck cancer translational research within Radiation Therapy Oncology Group: A report from the Translational Research Program Int J Radiat Oncol Biol Phys. 2007, Vol 69, No 2 Suppl, pS67-S78.
21. 2007 Genomics and proteomics: Emerging technologies in clinical cancer research Crit Rev Oncol Hematol. 2007, Vol 61, No 1, p1-25
22. 2007 Single agent Irinotecan for the treatment of metastatic or recurrent squamous carcinoma of the head and neck (SCCHN) Clin Med Oncol. 2007, Vol 1, p67-71
23. 2006 Chapter 9: Esthesioneuroblastoma Barbara A. Murphy, Joseph M. Aulino, Christine H. Chung, Kim Ely, Robert Sinard and Anthony Cmelak.
24. 2006 Gene expression differences associated with HPV status in head and neck squamous cell carcinoma Clin Cancer Res. 2006, Vol 12, No 3, p701-709.
25. 2006 Increased EGFR gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas J Clin Oncol. 2006, Vol 24, No 25, p4170-4176.
26. 2006 Clinical applications of genomics in head and neck cancer Head Neck. 2006, Vol 28, No 4, p360-368.
27. 2006 Epidermal Growth Factor Receptor: An overview of trials in head and neck and lung cancer [Commentary ONCOL.2006, Vol 20, No 2, p162, 166.
28. 2006 Chapter 9: Esthesioneuroblastoma John Wiley & Sons, Ltd. 2006, p133-142.
29. 2004 Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression Cancer Cell. 2004, Vol 5, p489-500.
30. 2003 49 year-old male with locally advanced squamous cell carcinoma of the head and neck: The case for sequential chemoradiotherapy programs [Commentary] Clin Adv in Hematol & Oncol. 2003, Vol 1, No 1, p61-62.
31. 2002 Molecular portraits and the family trees of cancer Nat Genet. 2002, Suppl. Vol 32, p533-540.
32. 2000 In-frame deletions of BRCA1 may define critical functional domains Hum Genet. 2000, Vol 107, p385-390.
33. 1998 Detection of K-ras mutations in duodenal fluid-derived DNA: Can it be used to diagnose cancer of the pancreas Cancer. 1998, Vol 82, No 1, p96-103.
34. 1996 Clinical significance of K-ras oncogene activation in ampullary neoplasms J Clin Pathol. 1996, Vol 49, No 6, p460-464.

About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.